Cancer detection is considered as a challenging and invasive process. In the traditional process of biopsies the tissue from a turmor is removed surgically which is expensive, risky, and uncomfortable. Liquid biopsy is considered as a non-invasive technique that will help in the early detection of cancer. It offers hope to the clinicians and patients alike. This blog post will provide an overview on how the liquid biopsy process is helpful in the cancer diagnostics, the advancement that makes changes and the potential of this process to reshape cancer screening. To know more about latest trends and opportunities in the liquid biopsy market on Coherent Market Insights website.
What is Liquid Biopsy?
It is considered as a minimally invasive method that is used to detect cancer related genetic materials that circulates in the patient’s blood. As the traditional biopsy need tissue extraction from the patient body but in liquid biopsy can be analysed through urine, blood, and other body fluids. It is performed very quickly, with less risk to the patient, and provide potential of routine screening.
Advances in Liquid Biopsy technology
The advancement made in the field of liquid biopsy technology to detect cancer will be done with the breakthroughs such as molecular biology, bioinformatics, and genomics. With these advancement scientist can detect the minute amount of circulating tumor DNA, RNA in blood, and exosomes. These methods will provide the important information about the cancer types. Potential resistance treatment, and progression. This make liquid biopsy process an ideal tool for early diagnosis of cancer.
Technological Advancement:
- Increase Sensitivity and Specificity: Introduction of new technologies such as next generation sequencing and polymerase chain reaction is used to improve sensitivity in the liquid biopsy. These advancement enables early detection of cancer stage with a high degree of accuracy.
- Real-time Monitoring: It provide the clinicians to monitor patient’s response towards a treatment by monitoring real time changes in biomarkers process. This techniques will help in detecting relapses early, provide personalized treatment and offer a dynamic environment.
How Liquid Biopsy Differs From Traditional Biopsy Methods:
Traditional biopsy methods involves physically removing tumor cells for the purpose of examination. It is a type of invasive procedure that needs local anaesthesia and have risk of complication such as bleeding and infection. It is considered as a gold standard in the cancer diagnostics process. Moreover, these traditional methods of biopsy did not work if the area of tumor is hard to reach.
On the other hand, liquid biopsy is considered as a non-invasive, safe, and fast alternative. It enables the doctor to diagnose the cancer related genetic mutation and alternative from the blood and urine sample. In addition, clinicians can detect multiple cancer type with the help of liquid biopsy. It provide a broader view of patient’s health.
Clinical Benefits of Liquid Biopsy in Early Cancer detection
- Early Diagnosis: It has the ability to diagnose the cancer in its early stage when it is treatable. By identifying the cancer related tissues before arising the symptoms, liquid biopsy will help in dramatically improving patient outcomes.
- Reduce Patient Risk: they present low rate of risk as these biopsies are non-invasive in nature. This makes that methods safer for the individuals who don’t want to undergo any invasive procedure due to health conditions.
- Cost effective: these test are more affordable and require less amount of resources as compared to the traditional biopsy methods. This process require specialized equipment’s and trained personnel.
